Jay Yang

Tazemetostat for patients with relapsed or refractory follicular lymphoma: an open-label, single-arm, multicentre, phase 2 trial

The Lancet Oncology · 2020 · 487 citations

Targeting multiple signaling pathways: the new approach to acute myeloid leukemia therapy

Review · Signal Transduction and Targeted Therapy · 2020 · 175 citations